Business Context and Reporting Period
This Form 8-K was filed by Acasti Pharma Inc. on October 25, 2024. The filing reports a corporate name change to "Grace Therapeutics, Inc." effective October 28, 2024, and a corresponding change in the Nasdaq trading symbol from "ACST" to "GRCE."
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and branding updates rather than financial performance.
Material Changes
- Corporate Name: Changed from Acasti Pharma Inc. to Grace Therapeutics, Inc.
- Trading Symbol: Changed from ACST to GRCE.
- Effective Date: Changes take effect at the market open on October 28, 2024.
Outlook and Management Commentary
Management announced plans to hold a virtual Key Opinion Leader Event on November 20, 2024. The filing incorporates a press release (Exhibit 99.1) detailing these updates. No specific financial guidance, risk factors, or contingencies were disclosed in this document.
Key Facts for Investor Verification
- Verify the new ticker symbol "GRCE" on trading platforms starting October 28, 2024.
- Confirm the legal name change to Grace Therapeutics, Inc. in corporate registries.
- Review the attached press release (Exhibit 99.1) for details regarding the November 20, 2024, Key Opinion Leader Event.